The economics of TB control in developing countries

Bibliography

• DYE C, SCHEELE S, DOLIN P,PATHANIA V, RAVIGLIONE MC: Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country.WHO Global Surveillance and Monitoring Project. JAMA (1999) 282(7):677–686.
   Google Scholar
• ZULMA A, GRANGE A:Tuberculosis. Br. Med. (1998) 316:1962–1964.
   PubMedGoogle Scholar
• •Clear and concise overview of TB control.
   Google Scholar
• CEGIELSKI JP, CHIN DP, ESPINAL MA et al.: The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century. Infect. Dis. Clin. N. Am. (2002) 16(1):1–58.
   Google Scholar
• BESRA GS, KREMER L: Re-emergence of tuberculosis: strategies and treatment. Expert Opin. Investig. Drugs (2002) 11(2):153–157.
   PubMed Web of Science ®Google Scholar
• DE COCK KM, WILKINSON D: Tuberculosis control in resource-poor countries: alternative approaches in the era of HIV. Lancet (1995) 346:675–677.
   PubMed Web of Science ®Google Scholar
• LAWN DB, AFFUL B,ACHEAMPONG JW: Pulmonary tuberculosis: diagnostic delay in Ghanaianadults. Intl Tuberc. Lung Dis. (1998) 2(8):635–640.
   PubMedGoogle Scholar
• LIENHARDT C, ROWLEY J,MANNEH K et al.: Factors affecting time delay to treatment in a tuberculosis control programme in a sub-Saharan African country: the experience of The Gambia. bit.j Tuberc. Lung Dis. (2001) 3:233–239.
   Google Scholar
• MADEBO T, LINDTJORN B: Delay in treatment of pulmonary tuberculosis: an analysis of symptom duration among Ethiopian patients. Med. Gen. Med. (1999) 18:6.
   Google Scholar
• SALANIPONI FM, HARRIES AD, BANDA HT et al.: Care seeking behaviour and diagnostic processes in patients with smear-positive pulmonary tuberculosis in Malawi. Intl Tuberc. Lung Dis. (2000) 4(4):327–332.
   PubMedGoogle Scholar
• BEYERS N, GTE RP, SCHAAF HS et al.: Delay in diagnosis, notification and initiation of treatment and compliance in children with tuberculosis. Tuber. Lung Dis. (1994) 75(4):260–265.
   PubMedGoogle Scholar
• NEEDHAM DM, FOSTER SD, TOMLINSON G, GODFREY-FAUSSETT P: Socio-economic, gender and health services factors affecting diagnostic delay for tuberculosis patients in urban Zambia. Bop. Med. Int. Health (2001) 6:256–259.
   PubMed Web of Science ®Google Scholar
• ••A thorough examination of the factorsaffecting patient and doctor delay in the diagnosis of TB.
   Google Scholar
• Global Tuberculosis Control: WHO Report 2001. World Health Organization. Geneva, Switzerland (2001) (WHO/CDS/TB2001.287).
   Google Scholar
• PABLOS-MENDEZ A, GOWDA DK, FRIEDEN TR: Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework. Bull. WHO (2002) 80(6):489–495.
   PubMed Web of Science ®Google Scholar
• MURRAY C, STYBLO K, ROUILLON A. In: Disease Control Priorities in Developing Countries. Jamison D, Mosley WH, Measham AR, Bobadilla JL (Eds). Oxford: Oxford University Press (1993).
   Google Scholar
• CASTELO A, MATHIASI PA, IUNNES R et al.: Cost effectiveness of antituberculosis interventions. Pharmacoeconomics (1995) 8(5):385–399.
   PubMedGoogle Scholar
• FOSTERS: The economics of tuberculosis diagnosis and treatment. In: Tuberculosis: an Interdisciplinary Perspective. Porter JDH,Grange JM (Eds) Imperial College Press, London, UK (1999).A clear and concise examination of the economics of TB control.
   Google Scholar
• FRYATT RJ: Review of published cost-effectiveness studies on tuberculosis treatment programmes. Int. .1 Tuberc. Lung Dis. (1997) 1(2):101–109.
   Google Scholar
• •Although a little dated now, a thorough examination of the methods and results of published cost-effectiveness analyses of treatment programmes in developing countries.
   Google Scholar
• PIOT MA: A simulation model of casefinding and treatment in tuberculosis control programmes.WHO/TB/Tech.information/67.53.
   Google Scholar
• ALUOCH JA, EDWARDS EA,STOTT H, FOX W, SUTHERLAND I: A fourth study of case-finding methods for pulmonary tuberculosis in Kenya. Trans. R. Soc. Bop. Med. Hyg. (1982) 76:679–691.
   PubMedGoogle Scholar
• LAWN SD et al.: Delay in the diagnosis of tuberculosis: a great new cost. hat. Tuberc. Lung Dis. (1997) 1(5):485–486.
   PubMedGoogle Scholar
• NEEDHAM DM,GODFREY-FAUSSETT P: Economic barriers for tuberculosis patients in Zambia. Lancet (1996) 348:134–135.
   PubMedGoogle Scholar
• HARRIES AD, KAMENYA A, SUBRAMANYAM VR et al: Screening pulmonary tuberculosis suspects in Malawi: testing different strategies. Trans. R. Soc. Bop. Med. Hyg. (1997) 91(4):416–419.
   PubMedGoogle Scholar
• SAUNDERSON PR: An economic evaluation of alternative programme designs for tuberculosis control in rural Uganda. Soc. ScL Med. (1995) 40:1203–1212.
   PubMed Web of Science ®Google Scholar
• LEONARD KL: Incentives in rural health care delivery: Cameroon. In: Africa.'r Changing Markets for Health and Veterinary Services: The New Institutional Issues. Leonard DK (Ed.), Macmillan Press, New York, USA (2000).
   Google Scholar
• VAIDYANATHAN, K, LIMBURG H, FOSTER A, PANDEY RM: Changing trends in barriers to cataract surgery in India. Bull. WHO (1999) 77(2):104–109.
   PubMed Web of Science ®Google Scholar
• AHLBURG DA: The Economic Impacts of Tuberculosis. Geneva, Switzerland: World Health Organization (2000).
   Google Scholar
• LIEFOOGHE R, MICHIELS RN, HABIB S, MORAN MB, DEMUYNCK A Perception and social consequences of tuberculosis: A focus group study of tuberculosis patients in Sialkot, Pakistan. Soc. ScL Med. (1995) 41(12):1685–1692.
   PubMed Web of Science ®Google Scholar
• UPLEKAR M, RANGAN S: Tackling TB: The Search for Solutions. The Foundation for Research in Community Health, Mumbai, India (1996).
   Google Scholar
• UPLEKAR M, JUVEKAR S,MORANKAR S, RANGAN S, NUNN P: Tuberculosis patients and practitioners in private clinics in India. Intl-. Tuberc. Lung Dis. (1998) 2(4):324–329.
   PubMed Web of Science ®Google Scholar
• MARSH D, HASHIM R, HASSANY F et al.: 1996. Front-line management of pulmonary tuberculosis: an analysis of tuberculosis and treatment practices in urban Sindh, Pakistan. Tuber. Lung Dis. (1996) 77(1):86–92.
   Google Scholar
• LONROTH K, THOUNG LM, LINH PD, DIWAN VK: Utilization of private and public health care providers among people with symptoms of tuberculosis in Ho CH Minh City, Vietnam. Health Policy Plan. (2001) 16(1):47–54.
   Google Scholar
• NSHUTI L: The role of private providers in the care of tuberculosis patients in Uganda MPh dissertation. Case Western Reserve University, Cleveland, Ohio and Makerere University, Kampala, Uganda (1998).
   Google Scholar
• WALKER D: Economic analysis of tuberculosis diagnostic tests in disease control: how can it be modelled and what additional information is needed? Int.j Tuberc. Lung Dis. (2001) 5(12):1099–1108.
   Google Scholar
• ••A comprehensive review of the economicsof TB diagnosis.
   Google Scholar
• ENARSON DA, RIEDER HL,ARNADOTTIR T: Tuberculosis Guide for Low Income Countries, 3rd edn. International Union Against Tuberculosis and Lung Disease, Paris, France (1994).
   Google Scholar
• HARRIES AD, MPHASA NB,MUNDY C, BANERJEE A,KWANJANA JH, SALANIPONI FML: Screening tuberculosis suspects using two sputum smears. hat. Tuberc. Lung Dis. (2000) 4(1):36–40.
   PubMedGoogle Scholar
• WALKER D, MCNERNEY R, KIMANKINDA MWEMBO M, FOSTERS, TIHON V, GODFREY-FAUSSETT P:An incremental cost-effectiveness analysis of the first, second and third sputum examination in the diagnosis of pulmonary tuberculosis. Int. j Tuberc. Lung Dis. (2000) 4(3):246–251.
   PubMedGoogle Scholar
• ROOS BR, VAN CLEEFF MR,GITHUI WA et al.: Cost-effectiveness of the polymerase chain reaction versus smear
   Google Scholar
• ••examination for the diagnosis of tuberculosis in Kenya: a theoretical model. Int.j Tuberc. Lung Dis. (1998) 2(3):235–241.
   Google Scholar
• SCHIRM J, OOSTENDORP LA, MULDER JG: Comparison of Amplicor, in-house PCR, and conventional culture for detection of Mycobacterium tuberculosis in clinical samples. J. Clin. Microbiol (1995) 33(12):3221–3224.
   PubMedGoogle Scholar
• WILSON SM: Progress towards a simplified PCR and its application to diagnosis of tuberculosis. J. Clin. Microbiol (1993) 31(1):776–782.
   PubMedGoogle Scholar
• KWOK S: Avoiding false positives with PCR. Nature (1989) 339:237–238.
   PubMed Web of Science ®Google Scholar
• NOORDHOEK GT: Reliability of NAA for detection of Mycobacterium tuberculosic an international collaborative quality control study among 30 laboratories. .1. Clin. Microbiol (1996) 34(10):2522–2525.
   Google Scholar
• BRISSON-NOEL A, GICQUEL B, LECOSSIER D, LEVY-FREBAULT V, NASSIF X, HANCE AJ: Rapid diagnosis of tuberculosis by amplification of mycobacterial DNA in clinical samples. Lancet. (1989) 2(8671):1069–1071.
   PubMedGoogle Scholar
• FOULDS J, O'BRIEN R New tools for thediagnosis of tuberculosis: the perspective of developing countries. Int. J Tuberc. Lung Dis. (1998) 2(10):778–783.
   PubMedGoogle Scholar
• ZWARENSTEIN M, SCHOEMAN JH, VUNDULE C, LOMBARD CJ,TATLEY M: Randomised controlled trial of self-supervised and directly observedtreatment of tuberculosis. Lancet (1998) 352(9137):1340–1343. 45.The economics of TB drug development. The Global Alliance for TB Drug Development, New York, USA (2001).
   Google Scholar
• ••An up-to-date examination of issuespertaining to drug development.
   Google Scholar
• RAJESWARI R, BALASUBRAMANIAN R, MUNIYANDI M, GEETHARAMANI S, THRESA X, VENKATESAN P: Socio-economic impact of tuberculosis on patients and family in India. Int. I Tuberc. Lung Dis. (1999) 3(10):869–877.
   PubMed Web of Science ®Google Scholar
• NEEDHAM DM,GODFREY-FAUSSETT P, FOSTER SD: Barriers to tuberculosis control in urban Zambia: the economic impact and burden on patients prior to diagnosis. Int. Tuberc. Lung Dis. (1998) 2(10):811–817.
   PubMed Web of Science ®Google Scholar
• FARMER P, KIM JY: Community based approaches to the control of multidrug resistant tuberculosis: introducing DOTS-plus'. Br. Med. (1998) 317:671–674.
   PubMed Web of Science ®Google Scholar
• MOULDING TS, CAYMITTES M: Managing medication compliance of tuberculosis patients in Haiti with medication monitors. Int. J Tuberc. Lung Dir. (2002) 6(4):313–319.
   PubMedGoogle Scholar
• KHAN M, WALLEY J, WITTER S, IMRAN A, SAFDAR N: Costs and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan. Health Policy and Planning (2002) 17(2):178–186.
   PubMedGoogle Scholar
• ISLAM MA, WAKAI S, ISHIKAWA N, CHOWDHURY AMR, VAUGHAN JP: Cost-effectiveness of community health workers in tuberculosis control in Bangladesh. Bull. WHO (2002) 80:445–450.
   PubMed Web of Science ®Google Scholar
• MCPAKE B, MILLS A: What can we learnfrom international comparisons of health systems and health system reform? Bull. WHO (2000) 78(6):811–820.
   PubMed Web of Science ®Google Scholar
• FLOYD K, BLAN L, RAVIGLIONE M, LEE J-W: Resources required for global tuberculosis control. Science (2002) 295:2040–2041.
   PubMed Web of Science ®Google Scholar
• FINE PEM: Variation in protection by BCG: implications of and for heterologous immunity. Lancet (1995) 346:1339–1345.
   PubMed Web of Science ®Google Scholar
• BISHAI DM, MERCER D: Modeling theeconomic benefits of better TB vaccines. Int. I Tuberc. Lung Dis. (2001) 5(11):984–993.
   PubMedGoogle Scholar
• •A recent economic analysis that considers some of the desirable characteristics of a TB vaccine.
   Google Scholar